NOTCH3 and cancer: Therefore, complementary to the lower infiltration of CD8+ T cells, these checkpoint inhibitors form a counter-regulatory mechanism in cancer cells putatively driven by the high expression of NOTCH3, indicating a new mechanism of NOTCH signaling for facilitating immune escape.